{
    "id": "52904067",
    "text": "Cimlanod (development codes CXL-1427 and BMS-986231) is an experimental drug for the treatment of acute decompensated heart failure. It was discovered by Cardioxyl Pharmaceuticals, which was acquired by Bristol-Myers Squibb. It is a nitroxyl donor. Cimlanod is a prodrug of CXL-1020. A preliminary study showed efficacy in patients with class III and IV heart failure. A phase II clinical trial was completed in 2016. == References == Category:Experimental drugs Category:Furans Category:Sulfonamides ",
    "title": "Cimlanod"
}